These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28779545)

  • 1. Brexanolone as adjunctive therapy in super-refractory status epilepticus.
    Rosenthal ES; Claassen J; Wainwright MS; Husain AM; Vaitkevicius H; Raines S; Hoffmann E; Colquhoun H; Doherty JJ; Kanes SJ
    Ann Neurol; 2017 Sep; 82(3):342-352. PubMed ID: 28779545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
    Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mega-dose phenobarbital therapy for super-refractory status epilepticus.
    Byun JI; Chu K; Sunwoo JS; Moon J; Kim TJ; Lim JA; Jun JS; Lee HS; Lee WJ; Lee DY; Jeon D; Lee ST; Jung KH; Jung KY; Lee SK
    Epileptic Disord; 2015 Dec; 17(4):444-52. PubMed ID: 26575689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
    Kanes SJ; Colquhoun H; Doherty J; Raines S; Hoffmann E; Rubinow DR; Meltzer-Brody S
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus.
    Arya R; Rotenberg A
    Seizure; 2019 May; 68():89-96. PubMed ID: 30245007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric super-refractory status epilepticus treated with allopregnanolone.
    Broomall E; Natale JE; Grimason M; Goldstein J; Smith CM; Chang C; Kanes S; Rogawski MA; Wainwright MS
    Ann Neurol; 2014 Dec; 76(6):911-5. PubMed ID: 25363147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options in pediatric super-refractory status epilepticus.
    Arayakarnkul P; Chomtho K
    Brain Dev; 2019 Apr; 41(4):359-366. PubMed ID: 30528076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus.
    Farias-Moeller R; Bartolini L; Pasupuleti A; Brittany Cines RD; Kao A; Carpenter JL
    Neurocrit Care; 2017 Apr; 26(2):267-272. PubMed ID: 27553113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and mortality of super-refractory status epilepticus in adults.
    Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
    Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
    Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
    Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
    [No Abstract]   [Full Text] [Related]  

  • 14. Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity.
    Uchida Y; Terada K; Madokoro Y; Fujioka T; Mizuno M; Toyoda T; Kato D; Matsukawa N
    Acta Neurol Scand; 2018 Apr; 137(4):432-437. PubMed ID: 29313881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric refractory and super-refractory status epilepticus.
    Vasquez A; Farias-Moeller R; Tatum W
    Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol for the treatment of super-refractory status epilepticus.
    Strzelczyk A; Kortland LM; Knake S; Rosenow F
    Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weaning from antiseizure drugs after new onset status epilepticus.
    Chakraborty T; Hocker S
    Epilepsia; 2019 May; 60(5):979-985. PubMed ID: 30963565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with mortality in patients with super-refractory status epilepticus.
    Fang YT; Lee TL; Tu YH; Lin SH; Chien ME; Huang CW; Hsu KS; Wu YJ
    Sci Rep; 2022 Jun; 12(1):9670. PubMed ID: 35690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
    Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
    J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.